Literature DB >> 10873604

The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.

Y Yokoyama1, Y Takahashi, A Shinohara, X Wan, S Takahashi, K Niwa, T Tamaya.   

Abstract

Because the expression level of hTERT, a catalytic subunit of human telomerase, is a rate-limiting determinant of telomerase activity, hTERT mRNA would be an excellent target of hammerhead ribozymes for the regulation of telomerase activity. We studied the efficiency of several hammerhead ribozymes targeting hTERT mRNA by transient and stable transfection procedures. To screen the potency of the ribozymes, transient ribozyme transfection and telomerase determination were performed. The ribozyme targeting 13 nucleotides downstream from the 5'-end of hTERT mRNA (13-ribozyme) exhibited the strongest telomerase-inhibitory activity, and the ribozyme to target 59 nucleotides upstream from the poly(A) tail showed clear activity. A stable transfection study confirmed that the 13-ribozyme suppressed telomerase. These observations suggest that the 13-ribozyme can regulate telomerase activity and may possess potential for cancer therapy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873604     DOI: 10.1006/bbrc.2000.2939

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

3.  Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.

Authors:  Li Sun; Xu Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 4.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

5.  Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.

Authors:  Su-Xia Liu; Wen-Sheng Sun; Ying-Lin Cao; Chun-Hong Ma; Li-Hui Han; Li-Ning Zhang; Zhen-Guang Wang; Fa-Liang Zhu
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

6.  Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.

Authors:  Zhi-Ming Hao; Jin-Yan Luo; Jin Cheng; Quan-Yin Wang; Guang-Xiao Yang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

Review 7.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

8.  Polyunsaturated fatty acids ameliorate aging via redox-telomere-antioncogene axis.

Authors:  Jingnan Chen; Yan Wei; Xinyu Chen; Jingjing Jiao; Yu Zhang
Journal:  Oncotarget       Date:  2017-01-31

Review 9.  An introduction to telomeres and telomerase.

Authors:  Michael C Bibby
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

Review 10.  Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations.

Authors:  Mohd Amir; Parvez Khan; Aarfa Queen; Ravins Dohare; Mohamed F Alajmi; Afzal Hussain; Asimul Islam; Faizan Ahmad; Imtaiyaz Hassan
Journal:  Cells       Date:  2020-02-04       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.